Systemic Jia Foundation
501C3 Nonprofit Organization Information
Systemic Jia Foundation is a 501(c)(3) charitable nonprofit in Mountain View, California (EIN 82-2564392). It has been tax-exempt since November 2018, and contributions to it are tax-deductible. Its Form 990 for tax year 2024 reports total revenue of $159,459 and net assets of $106,554. TaxExemptWorld has Form 990s on file for 7 tax years (2017–2024). The IRS classifies its activity as Pediatrics Research (NTEE H98). It is one of 936 nonprofits in Mountain View, CA.
Form 990 · Tax period ending Dec 2024 · Filed May 15, 2025 · From the IRS e-file data
Dollar amounts for every revenue and expense line are in the full 990 report.
Mission (as filed): 1. TO SUPPORT RESEARCH RELATING TO TREATMENTS AND CURE OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA); 2. PROMOTE INCREASED AWARENESS, KNOWLEDGE AND UNDERSTANDING OF SJIA BY MEDICAL PROFESSIONALS, THE GENERAL PUBLIC AND FAMILIES AFFECTED BY SJIA; 3. PROMOTE MUTUAL SUPPORT THROUGH BUILDING AND MAINTAINING AN EXTENSIVE WEB-BASED OR OTHER NETWORK OF INFORMATION AND RESOURCES FOR THE GENERAL PUBLIC AND FAMILIES.
SYSTEMIC JIA FOUNDATION PLANS SEVERAL TYPES OF FUNDRAISING: 1) DONATIONS FROM FAMILIES WITH SJIA: THE SYSTEMIC JIA FOUNDATION WILL REACH OUT TO FAMILIES WITH SJIA TO BOTH CONTRIBUTE AND RAISE FUNDS FOR THE BENEFIT OF THE SYSTEMIC JIA FOUNDATION. THE SYSTEMIC JIA FOUNDATION WILL RAISE FUNDS ONLINE, USING FUNDRAISING SITES SUCH AS CROWDRISE, STRIPE, FACEBOOK OR FUNDRAISING FUNCTIONALITY ON OUR OWN WEBSITE.2) EVENT SPONSORSHIPS FROM PHARMA COMPANIES: FOR ANY EVENTS THE SYSTEMIC JIA FOUNDATION ORGANIZE, THE SYSTEMIC JIA FOUNDATION WILL REACH OUT TO PHARMA COMPANIES WHO ARE INTERESTED IN SJIA TO G…
CONFERENCES ATTENDED IN 2024PRES CONGRESS 2024 ATTENDED FROM SEPTEMBER 11, 2024 TO SEPTEMBER 14, 2024 AT GOTHENBURG SWEDEN.BRIEF DESCRIPTION: THE PRES (PEDIATRIC RHEUMATOLOGY EUROPEAN SOCIETY) CONFERENCE IS AN ANNUAL INTERNATIONAL EVENT FOCUSED ON ADVANCEMENTS IN PEDIATRIC RHEUMATOLOGY. IT'S A PLATFORM FOR HEALTHCARE PROFESSIONALS, RESEARCHERS, AND SCIENTISTS TO NETWORK, LEARN, AND SHARE THEIR KNOWLEDGE ON DIAGNOSING, TREATING, AND MANAGING RHEUMATIC DISEASES IN CHILDREN AND YOUNG PEOPLE.
NEXTGEN 2024 ORGANIZED FROM WEDNESDAY NOVEMBER 13, 2024 TO FRIDAY, NOVEMBER 15, 2024.DESCRIPTION: NEXTGEN CONFERENCE (AS WITH NEXTGEN IN PREVIOUS YEARS) AIMS TO ADVANCE THERAPIES FOR SJIA, STILL'S DISEASE AND MAS. THE SPECIFIC FOCUS IN 2024 IS ON CLINICAL TRIALS AND BONE MARROW TRANSPLANTATION AS AN OPTION FOR REFRACTORY DISEASE. THE FOUNDATION INVITES ALL STAKEHOLDERS TO THE TABLE SUCH AS SCIENTISTS, CLINICIANS, PATIENT AND CAREGIVER REPRESENTATIVES, THE FDA / EMA, AND PHARMACEUTICAL COMPANIES.TOPICS INCLUDE:A COMPREHENSIVE LOOK AT IL18 (MEASURING IT, ROLE IN DISEASE, IL18-DRIVEN CLINICAL TR…
Public charity (509(a)(1), 170(b)(1)(A)(vi)) · 100.0% public support
Prepared by TaxExemptWorld from IRS Form 990 e-file data (object ID 202511359349300216). Not an official IRS form.